Top Stories
The Swiss startup aims to restore autonomy for people living with severe neurological conditions, including ALS, spinal cord injury and stroke.
CEO Jason Haider said the platform provides range-of-motion assessments "without the need for reflective markers or wearable sensors."
The deal will give Tempus control of a whole-genome blood test already covered by Medicare in three indications, after two years of co-commercialising it with Personalis.
Company says new 'powerful AI factory' will improve decision-making from discovery through clinical development.
The surgical robotics company will hold a special meeting Tuesday for shareholders to vote on a proposal to liquidate its assets.
Conference News
LumiMind unveiled its LumiSleep D1 sleep-aid headband at the 2026 World Artificial Intelligence Conference (WAIC) as it seeks to bring neuroscience technologies into the consumer market, Yicai Global ...
HONG KONG and SHANGHAI, July 21, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group"; HKEX: 2318; SSE: 601318) unveiled a range of innovative...
HINGHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, will be participating at this ...
Abstracts presented at American Society of Pain & Neuroscience (ASPN) annual meeting across surgical decision support and basivertebral nerve ablationEarly findings from real-world evidence study demo...
Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for...Advanc...
